What is fiction - .22 dilution or big pharma not interested?
No excuses when LP dilutes in pennies post UK approval and no credible, institutional investors or big pharma show up post approval, ok? I don’t want to hear any more excuses like Flaskworks, low share price, 2 more years, quick, new trials, etc